Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.

Gynecologic oncology - 1 Nov 2015

Frey Melissa K, Kim Sarah H, Bassett Rebecca Yee, Martineau Jessica, Dalton Emily, Chern Jing-Yi, Blank Stephanie V

Abstract excerpt

OBJECTIVE: The availability of next-generation sequencing and identification of multiple cancer-related genes has caused a shift away from single gene testing towards multi-gene panel testing for hereditary cancer syndromes. However, the utility of panels in individuals who previously underwent non-informative genetic screening has yet to be evaluated. We aim to evaluate the use of rescreening and results of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Triphosphatases
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to DNA Repair Enzymes

Share to Genes, BRCA2

Share to Mismatch Repair Endonuclease PMS2

Share to MutL Protein Homolog 1

Share to Uterine Neoplasms

Source

Identifiers

PMID: 26296696
DOI: 10.1016/j.ygyno.2015.08.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.PMID 26296696Read ↗

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.Semantic proximity Read ↗

Effects of Cancer Genetic Panel Testing on at-Risk Individuals.Semantic proximity Read ↗

Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria.Semantic proximity Read ↗

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.Semantic proximity Read ↗

Multigene Testing for Hereditary Cancer: When, Why, and How.Semantic proximity Read ↗

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Outcomes of retesting BRCA negative patients using multigene panels.Semantic proximity Read ↗

Inherited Cancer in the Age of Next-Generation Sequencing.Semantic proximity Read ↗

Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice.Semantic proximity Read ↗

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.Semantic proximity Read ↗

Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratorySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.